We are live on ! Find out more
MIP

Mondrian Investment Partners Portfolio holdings

AUM $6.69B
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.21B
AUM Growth
-$993M
Cap. Flow
-$316M
Cap. Flow %
-5.09%
Top 10 Hldgs %
51.3%
Holding
90
New
2
Increased
22
Reduced
34
Closed

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$273M
2
CAG icon
Conagra Brands
CAG
+$54.8M
3
INFY icon
Infosys
INFY
+$41.1M
4
IBM icon
IBM
IBM
+$34M
5
INGR icon
Ingredion
INGR
+$25.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.81%
2 Financials 14.06%
3 Technology 12.99%
4 Consumer Discretionary 12.11%
5 Utilities 11.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$40.4B
$634M 10.22%
11,029,486
-4,895,292
-31% -$273M
YUM icon
2
Yum! Brands
YUM
$41.9B
$480M 7.73%
9,163,222
+18,023
+0.2% +$939K
PHI icon
3
PLDT
PHI
$4.32B
$352M 5.68%
5,564,448
+94,772
+2% +$6.28M
BAP icon
4
Credicorp
BAP
$30.5B
$319M 5.14%
1,989,989
-124,262
-6% -$19.7M
MR
5
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$288M 4.64%
10,917,900
+305,900
+3% +$8.95M
ENIA
6
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$285M 4.59%
32,959,470
-1,618,360
-5% -$13.9M
BSMX
7
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$246M 3.96%
23,748,407
+1,766,600
+8% +$20.7M
VALE.P
8
DELISTED
Vale S A
VALE.P
$219M 3.53%
30,203,814
+817,000
+3% +$6.62M
INFY icon
9
Infosys
INFY
$51B
$206M 3.31%
26,149,600
-5,072,000
-16% -$41.1M
TSM icon
10
TSMC
TSM
$1.94T
$154M 2.48%
6,882,438
-92,579
-1% -$2.02M
AVY icon
11
Avery Dennison
AVY
$12.8B
$144M 2.32%
2,779,514
+496,914
+22% +$23.6M
BCE icon
12
BCE
BCE
$20.8B
$141M 2.27%
2,647,900
-14,900
-0.6% -$669K
CAE icon
13
CAE Inc. Common Shares
CAE
$8.44B
$139M 2.24%
9,197,581
+3,034,532
+49% +$39.1M
INGR icon
14
Ingredion
INGR
$6.42B
$124M 2%
1,465,665
-321,482
-18% -$25.6M
PFE icon
15
Pfizer
PFE
$143B
$122M 1.96%
4,115,981
+2,367,674
+135% +$67.9M
MSFT icon
16
Microsoft
MSFT
$2.9T
$113M 1.83%
2,440,577
-353,723
-13% -$16.6M
BAX icon
17
Baxter International
BAX
$12.8B
$112M 1.81%
2,818,637
-152,369
-5% -$5.93M
IBM icon
18
IBM
IBM
$213B
$107M 1.72%
694,813
-213,952
-24% -$34M
ABEV icon
19
Ambev
ABEV
$47.9B
$94M 1.51%
15,111,100
+2,816,000
+23% +$17.8M
UNH icon
20
UnitedHealth
UNH
$382B
$89.1M 1.44%
881,406
-80,494
-8% -$7.63M
CPL
21
DELISTED
CPFL Energia S.A.
CPL
$87.3M 1.41%
6,805,742
+271,183
+4% +$3.74M
PG icon
22
Procter & Gamble
PG
$340B
$79.7M 1.29%
875,488
-53,112
-6% -$4.67M
SYY icon
23
Sysco
SYY
$40.8B
$77.7M 1.25%
1,958,028
-181,172
-8% -$7.02M
RBA icon
24
RB Global
RBA
$21.5B
$76.8M 1.24%
2,460,100
+45,700
+2% +$1.13M
EPAC icon
25
Enerpac Tool Group
EPAC
$1.86B
$71.5M 1.15%
2,625,129
+405,707
+18% +$12.1M

Similar funds

Mondrian Investment Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Mondrian Investment Partners held 90 positions worth $6.21B, down 14% from $7.2B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Mondrian Investment Partners withdrew a net $316M in Q4 2014, reducing 34 holdings. Its largest reduction was Teva Pharmaceuticals, cutting an estimated $273M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

Against the trend, Mondrian Investment Partners opened a new position in Mastercard worth $18.5M.

  • Mondrian Investment Partners's largest Q4 2014 buy was Mastercard: 214,800 shares worth $18.5M.
  • Mondrian Investment Partners added most to Pfizer in Q4 2014, an estimated $67.9M increase.
  • Mondrian Investment Partners's biggest Q4 2014 reduction was Teva Pharmaceuticals, cutting an estimated $273M.
  • Mondrian Investment Partners's ten largest holdings make up 51% of its $6.21B portfolio in Q4 2014.
  • Mondrian Investment Partners opened 2 new positions and closed 0 in Q4 2014.
  • Mondrian Investment Partners's portfolio value fell 14% quarter-over-quarter to $6.21B.

Based on Mondrian Investment Partners's 13F filing for Q4 2014, filed 27 Jan 2015.